Soru

Zorluk: OrtaPediatric Genetic and Metabolic Disorders

A 10-day-old female infant is brought to the pediatrician's clinic for a follow-up visit. Her state newborn screening test, collected at 48 hours of life, returned positive for an isolated, markedly elevated phenylalanine level. The infant was born at term following an uncomplicated pregnancy and is currently exclusively breastfed. She appears active and healthy, and her physical examination is unremarkable. Arrange the following diagnostic and management steps in the most appropriate chronological order.

  1. 1Obtain a confirmatory quantitative plasma amino acid profile
  2. 2Initiate a phenylalanine-restricted diet supplemented with specialized medical formula
  3. 3Evaluate for tetrahydrobiopterin (BH4) deficiency using a urinary pterin profile and blood enzyme assays
  4. 4Titrate dietary phenylalanine intake based on routine blood monitoring

Cevap

The correct sequence is: 1) Confirm the screen with quantitative plasma amino acids, 2) Initiate a phenylalanine-restricted diet, 3) Evaluate for BH4 deficiency, and 4) Perform ongoing dietary monitoring and titration.
The standard of care for an abnormal newborn screen indicating elevated phenylalanine is to first confirm the finding with a quantitative plasma amino acid profile. Once hyperphenylalaninemia is confirmed, a phenylalanine-restricted diet must be initiated immediately to prevent irreversible cognitive impairment. Subsequently, further testing is required to differentiate classical phenylketonuria (PAH deficiency) from tetrahydrobiopterin (BH4) cofactor deficiency, as the latter requires additional specific therapies. Finally, ongoing titration of the diet is required throughout life to maintain phenylalanine in a narrow therapeutic window, allowing for normal somatic growth while preventing neurotoxicity.

Adım Adım Çözüm

1
Order quantitative plasma amino acid analysis.
Confirms true hyperphenylalaninemia versus a false-positive newborn screen.
Newborn screens are designed to be highly sensitive and can yield false positives; a diagnostic test is strictly required before starting restrictive therapies.
2
Start a phenylalanine-restricted diet.
Rapidly lowers plasma phenylalanine levels into a safe range.
Immediate treatment is necessary once the diagnosis is confirmed to prevent irreversible neurodevelopmental delay.
3
Test for BH4 deficiency.
Identifies whether a rare cofactor defect is the underlying etiology.
A small percentage of patients have BH4 deficiency (malignant PKU), which requires neurotransmitter precursor supplementation (L-dopa, 5-hydroxytryptophan) in addition to dietary control.
4
Monitor blood phenylalanine levels regularly.
Ensures levels remain in the therapeutic range (typically 120-360 micromol/L).
Children need an exact amount of essential phenylalanine for normal physical growth and development, necessitating constant dietary titration.

Anahtar Kavram

Chronological approach to the diagnosis and management of hyperphenylalaninemia (Phenylketonuria).
Bu soruyu puanla